Revolutionizing Cancer Treatment
The Power of Molecularly Imprinted Polymers for Precision Therapy
- 1st Edition - April 1, 2026
- Latest edition
- Editors: Bhupendra G. Prajapati, Devesh U. Kapoor, Anand Krishnan, Rishabha Malviya
- Language: English
Revolutionizing Cancer Treatment: The Power of Molecularly Imprinted Polymers for Precision Therapy examines the transformative role of molecularly imprinted polymers (MIPs) in can… Read more
Revolutionizing Cancer Treatment: The Power of Molecularly Imprinted Polymers for Precision Therapy examines the transformative role of molecularly imprinted polymers (MIPs) in cancer management and treatment. This comprehensive book explores how MIPs can be utilized to create advanced drug delivery systems specifically targeting various cancer types, including breast, prostate, and lung cancers, among others. By integrating molecular imprinting techniques with precision oncology, this resource provides valuable insights for researchers, clinicians, and pharmaceutical developers aiming to enhance cancer therapies. Structured in a user-friendly format, the book includes detailed chapters dedicated to specific cancer types, highlighting the design and application of MIPs in targeted therapies.
Users will find flow charts, process diagrams, and case studies to facilitate understanding of complex concepts. The necessity for this book arises from the pressing demand for precision medicine in oncology, as conventional treatments often suffer from issues of specificity and efficacy. Ultimately, this work serves as a vital reference for students, researchers, and healthcare professionals dedicated to advancing cancer treatment through innovative drug delivery systems.
Users will find flow charts, process diagrams, and case studies to facilitate understanding of complex concepts. The necessity for this book arises from the pressing demand for precision medicine in oncology, as conventional treatments often suffer from issues of specificity and efficacy. Ultimately, this work serves as a vital reference for students, researchers, and healthcare professionals dedicated to advancing cancer treatment through innovative drug delivery systems.
- Focuses on a distinct cancer type (e.g., breast, prostate, pancreatic, and lung), detailing how MIPs can be tailored for drug delivery and treatment
- Provides a solid foundation in the principles and latest advancements of this technology, addressing challenges and opportunities for researchers and industrial professionals seeking to innovate or enhance current therapeutic techniques
- Emphasizes how MIPs can serve as precision tools in cancer therapy
- Delves into various molecular imprinting methods used to develop MIP-based drug delivery systems
Researchers and students in the fields of pharmaceutical sciences, oncology, and biomedical engineering
1. Introduction
2. Molecular imprinting techniques in the development of molecularly imprinted polymers-based drug delivery systems for cancer
3. Targeting Breast Cancer: Innovations with Molecularly Imprinted Polymers.
4. Targeting Prostate Cancer: Innovations with Molecularly Imprinted Polymers.
5. Targeting Pancreatic Cancer: Innovations with Molecularly Imprinted Polymers.
6. Targeting Lung Cancer: Innovations with Molecularly Imprinted Polymers.
7. Targeting Brain Cancer: Innovations with Molecularly Imprinted Polymers.
8. Targeting Ovarian Cancer: Innovations with Molecularly Imprinted Polymers.
9. Targeting Liver Cancer: Innovations with Molecularly Imprinted Polymers.
10. Targeting Cervical Cancer: Innovations with Molecularly Imprinted Polymers.
11. Targeting Colon Cancer: Innovations with Molecularly Imprinted Polymers.
12. Molecularly imprinted polymers as precision tools in cancer
2. Molecular imprinting techniques in the development of molecularly imprinted polymers-based drug delivery systems for cancer
3. Targeting Breast Cancer: Innovations with Molecularly Imprinted Polymers.
4. Targeting Prostate Cancer: Innovations with Molecularly Imprinted Polymers.
5. Targeting Pancreatic Cancer: Innovations with Molecularly Imprinted Polymers.
6. Targeting Lung Cancer: Innovations with Molecularly Imprinted Polymers.
7. Targeting Brain Cancer: Innovations with Molecularly Imprinted Polymers.
8. Targeting Ovarian Cancer: Innovations with Molecularly Imprinted Polymers.
9. Targeting Liver Cancer: Innovations with Molecularly Imprinted Polymers.
10. Targeting Cervical Cancer: Innovations with Molecularly Imprinted Polymers.
11. Targeting Colon Cancer: Innovations with Molecularly Imprinted Polymers.
12. Molecularly imprinted polymers as precision tools in cancer
- Edition: 1
- Latest edition
- Published: April 1, 2026
- Language: English
BP
Bhupendra G. Prajapati
Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences.
Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, IndiaDK
Devesh U. Kapoor
Dr. Devesh U. Kapoor is currently serving as a Professor at Dr. Dayaram Patel Pharmacy College, Bardoli, District Surat, Gujarat. The institution is funded by the Directorate of Technical Education (DTE), Government of Gujarat, and is affiliated with Gujarat Technological University. Dr. Kapoor is alumnus of University of Rajasthan, Jaipur and Department of Pharmaceutics, BN College of Pharmacy, Rajasthan University of Health Sciences, Jaipur, Rajasthan, India. He was awarded a Ph.D. in Pharmaceutical Sciences in 2013. Dr. Kapoor serves as an Associate Editor for Naunyn-Schmiedebergs Archives of Pharmacology (Springer Nature), Future Journal of Pharmaceutical sciences (Springer Open), Scientific Reports (Springer Nature), Recent Advances in Drug Delivery & Formulation (Bentham Science) and PLOS One, Frontiers in Medicine - Precision Medicine and Frontiers in surgery. He is a Consulting Editor for Cytotechnology (Springer). He has peer-reviewed manuscripts for approximately 135 prestigious journals from publishers such as Elsevier, MDPI, Springer, Wiley, Frontiers, Dove Press, Bentham Science, Taylor & Francis, Wolters Kluwer (Medknow), and De Gruyter. With over 20 years of experience in teaching and academic administration, Dr. Kapoor has published more than 175 research and review articles in reputed national and international journals. In addition to his editorial responsibilities, Dr. Kapoor is currently editing 18 international books with publishers such as Elsevier, Springer, Wiley, Taylor & Francis, CRC Press, RSC. He has also contributed 50 book chapters published by renowned publishers including Elsevier, Bentham Science, MDPI, Springer, RSC and Wiley. He is currently supervising four Ph.D. students, focusing on nanodrug delivery systems and modified drug release from Gujarat Technological University, Ahemdabad. He fetched research and event organization grants from various government bodies including the Gujarat Council of Science & Technology (GUJCOST), Gujarat State Biotechnology Mission (GSBTM), and AICTE-ATAL for national seminars and faculty development programs. Dr. Kapoor holds 8 design patents and has delivered over 20 expert talks. He is frequently invited to speak at scientific sessions in national conferences, seminars, and workshops.
Affiliations and expertise
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, IndiaAK
Anand Krishnan
Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.
Affiliations and expertise
Precision Medicine and Integrated Nano-Diagnostics (P-MIND) Research Group, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein, South AfricaRM
Rishabha Malviya
Rishabha Malviya, did his PhD (Pharmacy) work in the area of novel formulation development techniques. He has 12 years of research experience and presently works as an Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University. His area of research interest includes formulation optimization, nano formulation, nanorobotic targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical drugs. He has authored more than 200 research/review papers for national/international journals of repute. He has 51 patents and has received an Outstanding Reviewer award from Elsevier. He has authored/edited/editing more than 70 books (Wiley, CRC Press, Springer Nature, River Publishers, De Gryuter, IOP publishing, Nova Science Publishers and Apple Academic Press) and authored 125 book chapters. His name is included in the world's top 2% of scientists in 2020, 2021 and 2022 by Elsevier and Stanford University.
Affiliations and expertise
Galgotias University, India